NAOMI ASAMOAH-BEAUFAIT: Open Payments
NPI 1093212524 · LANCASTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 43 payments from 16 companies in 2025. Trend: 2023 $1,546 · 2024 $1,975 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $295 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| Merck Sharp & Dohme LLC | 5 | $83 |
| PFIZER INC. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Boston Scientific Corporation | 3 | $56 |
| CVRx, Inc. | 2 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Philips North America LLC | 1 | $28 |
Products named: Kerendia, ELIQUIS, JARDIANCE, VERQUVO, SHINGRIX, WATCHMAN FLX, CAMZYOS, Barostim Neo System.
Industry payments across SC — which companies pay providers there.
